Nucleotide precursors (dNTPs/NTPs)

Nucleotide precursors are the fundamental chemical building blocks, consisting of purines and pyrimidines, necessary for the synthesis of DNA and RNA (NCBI, 2023). Beyond their role in genetic material, these molecules are vital for cellular energy transfer via ATP, intracellular signaling through cAMP, and the synthesis of essential coenzymes (StatPearls, 2023). In clinical pharmacology, these precursors are not typically the direct protein targets themselves; instead, the enzymes involved in their de novo synthesis and salvage pathways are targeted to modulate the available pool of nucleotides (Wikipedia, 2024). Rapidly dividing cells, such as those in malignant tumors or viral infections, have a heightened dependency on these precursors, making their depletion a primary strategy in chemotherapy and antiviral treatments (PubMed, 2022). Antimetabolite drugs function by mimicking the structure of these precursors to competitively inhibit key enzymes or by being erroneously incorporated into nucleic acid chains, leading to DNA damage and cell death (American Cancer Society, 2023).

Other names

Purine and pyrimidine precursorsNucleoside triphosphatesDeoxynucleoside triphosphatesNucleotide building blocksNucleic acid precursors

Antimetabolites interfere with nucleic acid synthesis by substituting for purines or pyrimidines (nucleotide precursors) during DNA and RNA synthesis or by inhibiting the enzymes necessary for their production, such as dihydrofolate reductase or thymidylate synthase (StatPearls, 2023; American Cancer Society, 2023).